Concepedia

Publication | Open Access

The FACT-targeted drug CBL0137 enhances the effects of rituximab to inhibit B-cell non-Hodgkin’s lymphoma tumor growth by promoting apoptosis and autophagy

17

Citations

49

References

2023

Year

References

YearCitations

Page 1